Dranitsaris G, Sutcliffe S. Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkins' and non-Hodgkins' lymphoma. Leukemia and Lymphoma 1995;17(1-2):139-145.
McQuaker I G, Hunter A E, Pacey S, Haynes A P, Iqbal A, Russell N H. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. Journal of Clinical Oncology 1997;15(2):451-457.
Zagonel V, Barbare R, Merola M C, Talamini R, Lazarini R, Tirelli U, et al. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy. Annals of Oncology 1994;5(supplement 2):S127-32.